Trending Stock News

Holder Bank Of New York Mellon Has Boosted Alnylam Pharmaceuticals (ALNY) Holding; Texas Instrs (TXN) Shares Rose While First Personal Financial Services Has Lifted Stake

First Personal Financial Services increased its stake in Texas Instrs Inc (TXN) by 132.13% based on its latest 2017Q3 regulatory filing with the SEC. First Personal Financial Services bought 5,914 shares as the company’s stock rose 5.05% with the market. The institutional investor held 10,390 shares of the semiconductors company at the end of 2017Q3, valued at $931,000, up from 4,476 at the end of the previous reported quarter. First Personal Financial Services who had been investing in Texas Instrs Inc for a number of months, seems to be bullish on the $103.41B market cap company. The stock increased 0.58% or $0.61 during the last trading session, reaching $105.18. About 1.65 million shares traded. Texas Instruments Incorporated (NASDAQ:TXN) has risen 40.31% since February 16, 2017 and is uptrending. It has outperformed by 23.61% the S&P500.

Bank Of New York Mellon Corp increased its stake in Alnylam Pharmaceuticals Inc (ALNY) by 2.44% based on its latest 2017Q3 regulatory filing with the SEC. Bank Of New York Mellon Corp bought 8,163 shares as the company’s stock rose 48.45% with the market. The institutional investor held 342,105 shares of the health care company at the end of 2017Q3, valued at $40.19M, up from 333,942 at the end of the previous reported quarter. Bank Of New York Mellon Corp who had been investing in Alnylam Pharmaceuticals Inc for a number of months, seems to be bullish on the $12.32B market cap company. The stock increased 1.47% or $1.783 during the last trading session, reaching $123.523. About 286,918 shares traded. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has risen 33.54% since February 16, 2017 and is uptrending. It has outperformed by 16.84% the S&P500.

Bank Of New York Mellon Corp, which manages about $363.33B US Long portfolio, decreased its stake in Gentherm Inc (NASDAQ:THRM) by 38,502 shares to 1.14 million shares, valued at $42.17 million in 2017Q3, according to the filing. It also reduced its holding in Tenaris Sa (NYSE:TS) by 18,191 shares in the quarter, leaving it with 307,683 shares, and cut its stake in Centerpoint Energy Inc (NYSE:CNP).

Since September 20, 2017, it had 0 insider buys, and 3 selling transactions for $23.18 million activity. 36,745 shares were sold by Mason Michael, worth $4.84M on Thursday, January 4.

Investors sentiment decreased to 0.92 in Q3 2017. Its down 0.60, from 1.52 in 2017Q2. It fall, as 30 investors sold ALNY shares while 73 reduced holdings. 40 funds opened positions while 55 raised stakes. 86.02 million shares or 0.72% more from 85.40 million shares in 2017Q2 were reported. Wellington Mgmt Grp Llp reported 11.30 million shares or 0.3% of all its holdings. Gp One Trading Ltd Partnership has 68,743 shares for 0.07% of their portfolio. Goldman Sachs Group invested in 0.05% or 1.79 million shares. M&T National Bank Corporation stated it has 4,060 shares or 0% of all its holdings. Tarbox Family Office Inc reported 20 shares. Artal Gp has invested 0.51% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Tocqueville Asset Mngmt Limited Partnership has 0.03% invested in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Proshare Advsr Ltd Company reported 0.06% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). The Ohio-based Victory Capital Management has invested 0.01% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). State Street Corp reported 0.02% of its portfolio in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Bank Of America Corp De holds 74,897 shares or 0% of its portfolio. Atika Management Ltd Liability Co reported 25,000 shares or 0.84% of all its holdings. Segall Bryant Hamill Ltd Liability Corp, Illinois-based fund reported 2,000 shares. Swiss Financial Bank reported 137,900 shares. Eaton Vance Management owns 31,866 shares.

Among 23 analysts covering Alnylam Pharmaceuticals (NASDAQ:ALNY), 17 have Buy rating, 1 Sell and 5 Hold. Therefore 74% are positive. Alnylam Pharmaceuticals had 96 analyst reports since August 7, 2015 according to SRatingsIntel. The company was maintained on Friday, January 19 by FBR Capital. The rating was upgraded by JP Morgan on Friday, March 11 to “Overweight”. Cowen & Co maintained Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on Thursday, September 21 with “Buy” rating. The rating was maintained by Leerink Swann with “Market Perform” on Thursday, September 21. The stock of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) earned “Buy” rating by BMO Capital Markets on Monday, June 26. The rating was downgraded by JP Morgan on Thursday, October 6 to “Neutral”. Chardan Capital Markets maintained the stock with “Buy” rating in Monday, June 12 report. Jefferies maintained it with “Buy” rating and $145.0 target in Monday, January 8 report. The rating was maintained by Piper Jaffray on Friday, December 15 with “Buy”. Piper Jaffray maintained Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on Thursday, November 2 with “Buy” rating.

Investors sentiment increased to 1.12 in 2017 Q3. Its up 0.02, from 1.1 in 2017Q2. It is positive, as 55 investors sold TXN shares while 333 reduced holdings. 104 funds opened positions while 332 raised stakes. 802.74 million shares or 3.16% more from 778.17 million shares in 2017Q2 were reported. First Manhattan Company holds 26,997 shares or 0.01% of its portfolio. Advsr Cap Lc reported 15,168 shares. 1,922 are owned by Salem Invest Counselors. Silvercrest Asset Management Ltd Liability holds 1.28% or 1.43 million shares in its portfolio. Jones Financial Cos Lllp accumulated 2,774 shares or 0% of the stock. Washington Trust Natl Bank holds 1,301 shares. Rnc Cap Limited Co reported 0.05% of its portfolio in Texas Instruments Incorporated (NASDAQ:TXN). Fifth Third National Bank invested 0.1% in Texas Instruments Incorporated (NASDAQ:TXN). Qs Invsts Ltd Liability Co holds 0.12% of its portfolio in Texas Instruments Incorporated (NASDAQ:TXN) for 168,624 shares. Lyons Wealth Limited Liability Co holds 1.38% or 10,201 shares in its portfolio. Cedar Hill Assocs Ltd Liability Corporation stated it has 101,237 shares or 1.57% of all its holdings. Northcoast Asset Ltd Liability stated it has 289,463 shares. Forward Management Limited Liability has 15,987 shares for 0.16% of their portfolio. Rockland Trust has 0.07% invested in Texas Instruments Incorporated (NASDAQ:TXN). Glenview Fincl Bank Dept reported 99,267 shares stake.

Since August 14, 2017, it had 0 insider purchases, and 29 selling transactions for $203.04 million activity. TEMPLETON RICHARD K sold $4.81M worth of stock. CRUTCHER BRIAN T sold $25.40 million worth of stock. The insider TROCHU CYNTHIA HOFF sold $395,472. XIE BING had sold 15,877 shares worth $1.73 million. ANDERSON STEPHEN A. sold $15.74 million worth of Texas Instruments Incorporated (NASDAQ:TXN) on Thursday, January 25. Shares for $4.95 million were sold by RITCHIE KEVIN J.

First Personal Financial Services, which manages about $474.22 million US Long portfolio, decreased its stake in General Electric Co (NYSE:GE) by 24,828 shares to 192,857 shares, valued at $4.66M in 2017Q3, according to the filing. It also reduced its holding in Keycorp New (NYSE:KEY) by 19,925 shares in the quarter, leaving it with 2,240 shares, and cut its stake in Ishares Inc (IEMG).

Leave a Reply

Your email address will not be published. Required fields are marked *